Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Holger Lingel

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Frontiers in Immunology|January 21, 2025
Long-term increase in soluble interleukin-6 receptor levels in convalescents after mild COVID-19 infectionJuliane Lokau, Yvonne Garbers, Manuel M Vicente, et al.
Cell Death and Differentiation|June 24, 2017
CTLA-4-mediated posttranslational modifications direct cytotoxic T-lymphocyte differentiationHolger Lingel, Josef Wissing, Aditya Arra, et al.
Frontiers in Immunology|September 5, 2025
SLAMF7 (CD319) enhances cytotoxic T-cell differentiation and sensitizes CD8<sup>+</sup> T cells to immune checkpoint blockadeJan-Erik Sander, Irina Han, Lisette Fickenscher, et al.
Cell Death and Differentiation|October 10, 2024
SLAMF7 (CD319) on activated CD8<sup>+</sup> T cells transduces environmental cues to initiate cytotoxic effector cell responsesHolger Lingel, Laura Fischer, Sven Remstedt, et al.
Cell Communication and Signaling : CCS|April 23, 2013
PAG/Cbp suppression reveals a contribution of CTLA-4 to setting the activation threshold in T cellsMichal Smida, Clemens Cammann, Slavyana Gurbiel, et al.
European Journal of Immunology|April 12, 2014
CTLA-4 (CD152) enhances the Tc17 differentiation programJonas Pick, Aditya Arra, Holger Lingel, et al.
Nature Communications|September 23, 2023
Bifidobacteria shape antimicrobial T-helper cell responses during infancy and adulthoodKatrin Vogel, Aditya Arra, Holger Lingel, et al.
Oncoimmunology|June 28, 2021
Immune-checkpoint blockade of CTLA-4 (CD152) in antigen-specific human T-cell responses differs profoundly between neonates, children, and adultsAditya Arra, Maximilian Pech, Hang Fu, et al.
Journal of Autoimmunity|July 2, 2021
Unique autoantibody prevalence in long-term recovered SARS-CoV-2-infected individualsHolger Lingel, Stefan Meltendorf, Ulrike Billing, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 1, 2020
Cell Survival Failure in Effector T Cells From Patients With Systemic Lupus Erythematosus Following Insufficient Up-Regulation of Cold-Shock Y-Box Binding Protein 1Stefan Meltendorf, Hang Fu, Mandy Pierau, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Frontiers in Immunology|January 21, 2025
Long-term increase in soluble interleukin-6 receptor levels in convalescents after mild COVID-19 infectionJuliane Lokau, Yvonne Garbers, Manuel M Vicente, et al.
Cell Death and Differentiation|June 24, 2017
CTLA-4-mediated posttranslational modifications direct cytotoxic T-lymphocyte differentiationHolger Lingel, Josef Wissing, Aditya Arra, et al.
Frontiers in Immunology|September 5, 2025
SLAMF7 (CD319) enhances cytotoxic T-cell differentiation and sensitizes CD8<sup>+</sup> T cells to immune checkpoint blockadeJan-Erik Sander, Irina Han, Lisette Fickenscher, et al.
Cell Death and Differentiation|October 10, 2024
SLAMF7 (CD319) on activated CD8<sup>+</sup> T cells transduces environmental cues to initiate cytotoxic effector cell responsesHolger Lingel, Laura Fischer, Sven Remstedt, et al.
Cell Communication and Signaling : CCS|April 23, 2013
PAG/Cbp suppression reveals a contribution of CTLA-4 to setting the activation threshold in T cellsMichal Smida, Clemens Cammann, Slavyana Gurbiel, et al.
European Journal of Immunology|April 12, 2014
CTLA-4 (CD152) enhances the Tc17 differentiation programJonas Pick, Aditya Arra, Holger Lingel, et al.
Nature Communications|September 23, 2023
Bifidobacteria shape antimicrobial T-helper cell responses during infancy and adulthoodKatrin Vogel, Aditya Arra, Holger Lingel, et al.
Oncoimmunology|June 28, 2021
Immune-checkpoint blockade of CTLA-4 (CD152) in antigen-specific human T-cell responses differs profoundly between neonates, children, and adultsAditya Arra, Maximilian Pech, Hang Fu, et al.
Journal of Autoimmunity|July 2, 2021
Unique autoantibody prevalence in long-term recovered SARS-CoV-2-infected individualsHolger Lingel, Stefan Meltendorf, Ulrike Billing, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 1, 2020
Cell Survival Failure in Effector T Cells From Patients With Systemic Lupus Erythematosus Following Insufficient Up-Regulation of Cold-Shock Y-Box Binding Protein 1Stefan Meltendorf, Hang Fu, Mandy Pierau, et al.
Pageof 3